AGI.do

Products

What will AGI do for Aglepristone?

This classification denotes an anti-progestin, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0UT4JLE1CM. European Medicines Agency schedules Aglepristone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05285MIG. Aglepristone generally arises in the molecular formula C29H37NO2. The term AGLEPRISTONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 8 no. 3 1994, list 34.) AGLEPRISTONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule aglepristone under HS 29225000 and SITC 51467. As of Q4 2014, AGLEPRISTONE remains the US FDA Preferred Term for this commodity. Aglepristone bears US NLM identifiers UMLS ID C0963581 and NCI Concept Code C78092. SMILES: OC1(C2(C(C3C(=C4C(=CC(=O)CC4)CC3)C(C2)c2ccc(N(C)C)cc2)CC1)C)/C=C\C.

How AGI delivers it

Four ways AGI delivers for Aglepristone

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Aglepristone, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Aglepristone, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Aglepristone connects

measured by

  • Active Ingredient Potencymodel
  • Compound Puritymodel
  • Residual Solventmodel

Go deeper

Explore Aglepristone

Read the deeper take on agi.asView as markdown